000 | 01392 a2200373 4500 | ||
---|---|---|---|
005 | 20250517120724.0 | ||
264 | 0 | _c20170206 | |
008 | 201702s 0 0 eng d | ||
022 | _a1941-9260 | ||
024 | 7 |
_a10.1080/00325481.2016.1243005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKushner, Pamela A | |
245 | 0 | 0 |
_aHypertriglyceridemia: the importance of identifying patients at risk. _h[electronic resource] |
260 |
_bPostgraduate medicine _cNov 2016 |
||
300 |
_a848-858 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aHypercholesterolemia _xblood |
650 | 0 | 4 |
_aHypertriglyceridemia _xdrug therapy |
650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
650 | 0 | 4 | _aLife Style |
650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xepidemiology |
650 | 0 | 4 |
_aPancreatitis _xepidemiology |
650 | 0 | 4 | _aRacial Groups |
650 | 0 | 4 |
_aRenal Insufficiency _xepidemiology |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aWeight Loss |
700 | 1 | _aCobble, Michael E | |
773 | 0 |
_tPostgraduate medicine _gvol. 128 _gno. 8 _gp. 848-858 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/00325481.2016.1243005 _zAvailable from publisher's website |
999 |
_c26489973 _d26489973 |